Vaxart, Inc. SEC filings VXRT

Vaxart, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to May 18, 2011. Its latest annual report, Form ARS, was filed on Jun 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Vaxart, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 19, 2026 Oct 16, 2026
8-K Current report
Other events
Sep 14, 2026 Sep 3, 2026
8-K Current report
Other events
Aug 25, 2026 Aug 21, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Other events
Jul 28, 2026 Jul 27, 2026
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jul 17, 2026 Jul 16, 2026
8-K Current report
Other events
Jul 7, 2026 Jul 6, 2026
DEFA14A Additional proxy material Jul 6, 2026 —
DEFA14A Additional proxy material Jul 2, 2026 —
DFAN14A Filing Jul 2, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 2, 2026 Jul 1, 2026
DEFA14A Additional proxy material Jul 1, 2026 —
DEFA14A Additional proxy material Jun 26, 2026 —
DEFA14A Additional proxy material Jun 26, 2026 —
8-K Current report
Material agreement, Other events
Jun 26, 2026 Jun 22, 2026
DEFA14A Additional proxy material Jun 26, 2026 —
DEFA14A Additional proxy material Jun 26, 2026 —
DFAN14A Filing Jun 22, 2026 —
DEFA14A Additional proxy material Jun 16, 2026 —
DEFA14A Additional proxy material Jun 16, 2026 —
DFAN14A Filing Jun 9, 2026 —
DEFA14A Additional proxy material Jun 8, 2026 —
DFAN14A Filing Jun 8, 2026 —
DEFA14A Additional proxy material Jun 8, 2026 —
DEFC14A Filing Jun 4, 2026 —
DEFA14A Additional proxy material Jun 1, 2026 —
ARS Annual report to shareholders Jun 1, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 1, 2026 —
DEFA14A Additional proxy material Jun 1, 2026 —
DEFC14A Proxy statement Jun 1, 2026 —
PRER14A Proxy statement May 29, 2026 —
PRRN14A Filing May 29, 2026 —
PREC14A Filing May 21, 2026 —
DEFA14A Additional proxy material May 20, 2026 —
DEFA14A Additional proxy material May 20, 2026 —
PREC14A Proxy statement May 19, 2026 —
DEFA14A Additional proxy material May 19, 2026 —
8-K Current report
Other events
May 19, 2026 May 19, 2026
DEFA14A Additional proxy material May 19, 2026 —
424B3 Prospectus May 19, 2026 —
EFFECT Filing May 18, 2026 —
S-1/A Amended registration statement May 18, 2026 —
S-1 Registration statement May 8, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
424B5 Prospectus supplement May 4, 2026 —
EFFECT Filing Apr 30, 2026 —
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
CORRESP Letter to the SEC Apr 29, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 23, 2026 Apr 23, 2026
UPLOAD Letter from the SEC Apr 21, 2026 —
8-K Current report
Other events
Apr 21, 2026 Apr 20, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 17, 2026 Apr 16, 2026
S-3 Shelf registration Apr 16, 2026 —
10-K Annual report Mar 13, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Agreement ended
Dec 29, 2025 Dec 18, 2025
25-NSE Delisting notice Nov 21, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
424B5 Prospectus supplement Nov 5, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Nov 5, 2025 Nov 4, 2025
8-K Current report
Regulation FD disclosure
Oct 10, 2025 Oct 8, 2025
8-K Current report
Listing notice
Sep 19, 2025 Sep 19, 2025
8-K Current report
Other events
Sep 19, 2025 Sep 18, 2025
PX14A6G Filing Sep 18, 2025 —
PX14A6G Filing Sep 10, 2025 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Sep 8, 2025 Sep 5, 2025
DEFA14A Additional proxy material Sep 8, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 2, 2025 Sep 2, 2025
PX14A6G Filing Sep 2, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Aug 29, 2025 Aug 27, 2025
DEFA14A Additional proxy material Aug 21, 2025 —
8-K Current report
Regulation FD disclosure
Aug 21, 2025 Aug 20, 2025
8-K Current report
Regulation FD disclosure
Aug 15, 2025 Aug 14, 2025
DEFA14A Additional proxy material Aug 15, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
DEFA14A Additional proxy material Aug 8, 2025 —
DEF 14A Proxy statement Aug 6, 2025 Sep 5, 2025
8-K Current report
Material agreement, Other events
Aug 6, 2025 Aug 5, 2025
PRE 14A Preliminary proxy statement Jul 24, 2025 Sep 5, 2025
8-K Current report
Other events
Jul 8, 2025 Jul 8, 2025
8-K Current report
Listing notice
Jul 2, 2025 Jul 1, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jun 17, 2025 Jun 13, 2025
8-K Current report
Other events
Jun 11, 2025 Jun 11, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jun 2, 2025 Jun 2, 2025
DEFA14A Additional proxy material May 29, 2025 —
PRE 14A Preliminary proxy statement May 29, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
May 28, 2025 May 28, 2025
DEFA14A Additional proxy material May 28, 2025 —
8-K Current report
Other events
May 28, 2025 May 27, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
May 22, 2025 May 21, 2025
DEFA14A Additional proxy material May 16, 2025 —
8-K Current report
Other events
May 16, 2025 May 16, 2025
DEFA14A Additional proxy material May 16, 2025 —
8-K Current report
Other events
May 15, 2025 May 15, 2025
8-K Current report
Officer or director change, Other events
May 13, 2025 May 12, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
DEFA14A Additional proxy material May 12, 2025 —
8-K Current report
Other events
May 12, 2025 May 12, 2025
DEFA14A Additional proxy material May 5, 2025 —
8-K Current report
Regulation FD disclosure
May 5, 2025 May 5, 2025
DEFA14A Additional proxy material Apr 28, 2025 —
8-K Current report
Material agreement, Other events
Apr 28, 2025 Apr 24, 2025
ARS Annual report to shareholders Apr 10, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 10, 2025 —
DEF 14A Proxy statement Apr 10, 2025 May 21, 2025
PRE 14A Preliminary proxy statement Mar 31, 2025 May 21, 2025
8-K Current report
Material agreement
Mar 21, 2025 Mar 21, 2025
424B5 Prospectus supplement Mar 21, 2025 —
8-K Current report
Results of operations
Mar 21, 2025 Mar 20, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Other events
Mar 11, 2025 Mar 11, 2025
8-K Current report
Material agreement, Other events
Feb 24, 2025 Feb 21, 2025
8-K Current report
Material agreement
Feb 10, 2025 Feb 7, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 28, 2025 Jan 24, 2025
8-K Current report
Other events
Jan 21, 2025 Jan 13, 2025
8-K Current report
Listing notice
Dec 31, 2024 Dec 31, 2024
8-K Current report
Material agreement
Dec 27, 2024 Dec 20, 2024
8-K Current report
Other events
Dec 5, 2024 Dec 2, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
424B5 Prospectus supplement Oct 8, 2024 —
8-K Current report
Agreement ended
Oct 8, 2024 Oct 8, 2024
8-K Current report
Material agreement, Other events
Sep 30, 2024 Sep 27, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Listing notice
Jul 5, 2024 Jul 2, 2024
S-8 Employee stock plan registration Jul 3, 2024 —
8-K/A Amended current report
Shareholder vote results
Jun 20, 2024 Jun 11, 2024
8-K Current report
Regulation FD disclosure
Jun 18, 2024 Jun 17, 2024
424B5 Prospectus supplement Jun 17, 2024 —
8-K Current report
Material agreement, Other events
Jun 14, 2024 Jun 13, 2024
8-K Current report
Material agreement, Other events
Jun 13, 2024 Jun 13, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 13, 2024 Jun 11, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
8-K Current report
Other events
Apr 30, 2024 Apr 30, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 11, 2024
PRE 14A Preliminary proxy statement Apr 18, 2024 Jun 11, 2024
S-8 Employee stock plan registration Mar 14, 2024 —
10-K Annual report Mar 14, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 14, 2024 Mar 14, 2024
8-K Current report
Officer or director change, Other events
Mar 6, 2024 Mar 4, 2024
8-K Current report
Officer or director change
Feb 29, 2024 Feb 27, 2024
8-K Current report
Other events
Feb 15, 2024 Feb 14, 2024
8-K/A Amended current report
Officer or director change
Feb 2, 2024 Jan 15, 2024
8-K Current report
Listing notice, Other events
Jan 19, 2024 Jan 19, 2024
424B5 Prospectus supplement Jan 18, 2024 —
8-K Current report
Material agreement, Other events
Jan 16, 2024 Jan 16, 2024
8-K Current report
Material agreement, Officer or director change, Other events
Jan 16, 2024 Jan 15, 2024
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K/A Amended current report
Shareholder vote results
Oct 23, 2023 Oct 18, 2023
8-K Current report
Bylaw or fiscal year change
Oct 23, 2023 Oct 18, 2023
8-K Current report
Other events
Sep 6, 2023 Sep 6, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Listing notice
Jul 26, 2023 Jul 21, 2023
8-K Current report
Other events
Jul 10, 2023 Jul 6, 2023
8-K Current report
Shareholder vote results
Jun 28, 2023 Jun 26, 2023
DEFA14A Additional proxy material Jun 21, 2023 —
8-K Current report
Material agreement, Other events
Jun 8, 2023 Jun 6, 2023
424B5 Prospectus supplement Jun 8, 2023 —
424B5 Prospectus supplement Jun 6, 2023 —
8-K Current report
Other events
Jun 6, 2023 Jun 6, 2023
8-K Current report
Other events
May 25, 2023 May 24, 2023
8-K Current report
Results of operations
May 9, 2023 May 4, 2023
424B5 Prospectus supplement May 9, 2023 —
EFFECT Filing May 5, 2023 —
10-Q Quarterly report May 4, 2023 Mar 31, 2023
CORRESP Letter to the SEC May 3, 2023 —
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 26, 2023
8-K Current report
Listing notice
Mar 31, 2023 Mar 31, 2023
UPLOAD Letter from the SEC Mar 23, 2023 —
S-3 Shelf registration Mar 17, 2023 —
8-K Current report
Results of operations
Mar 16, 2023 Mar 15, 2023
10-K Annual report Mar 15, 2023 Dec 31, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 19, 2022 Dec 15, 2022
8-K Current report
Other events
Dec 6, 2022 Nov 18, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
S-8 Employee stock plan registration Oct 24, 2022 —
8-K Current report
Regulation FD disclosure, Other events
Sep 1, 2022 Aug 31, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 25, 2022 Aug 23, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K/A Amended current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
Aug 5, 2022 Jul 6, 2022
8-K Current report
Other events
Jul 28, 2022 Jul 27, 2022
DEFA14A Additional proxy material Jul 26, 2022 —
DEFA14A Additional proxy material Jul 26, 2022 —
DEFA14A Additional proxy material Jul 12, 2022 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VXRT (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
72444
Former names
Aviragen Therapeutics, Inc. (until Feb 15, 2018); Biota Pharmaceuticals, Inc. (until Apr 13, 2016); NABI BIOPHARMACEUTICALS (until Nov 8, 2012); NABI BIOPHARMACEUTICALS (until Jun 29, 2010); NABI /DE/ (until Feb 14, 2002)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.